CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)	Common shares [Member]	Additional paid-in capital [Member]	Accumulated deficit [Member]	Total
Beginning Balance at Dec. 31, 2023	$ 18,761,250	$ 98,585	$ (17,748,387)	$ 1,111,448
Beginning Balance (Shares) at Dec. 31, 2023	8,076,673
Stock-based compensation	$ 0	35,953	0	35,953
Net loss and comprehensive loss for the period	0	0	(1,707,358)	(1,707,358)
Ending Balance at Mar. 31, 2024	$ 18,761,250	134,538	(19,455,745)	(559,957)
Ending Balance (Shares) at Mar. 31, 2024	8,076,673
Beginning Balance at Dec. 31, 2023	$ 18,761,250	98,585	(17,748,387)	1,111,448
Beginning Balance (Shares) at Dec. 31, 2023	8,076,673
Net loss and comprehensive loss for the period				(5,340,217)
Ending Balance at Jun. 30, 2024	$ 29,442,212	719,980	(23,088,604)	7,073,588
Ending Balance (Shares) at Jun. 30, 2024	10,846,721
Beginning Balance at Mar. 31, 2024	$ 18,761,250	134,538	(19,455,745)	(559,957)
Beginning Balance (Shares) at Mar. 31, 2024	8,076,673
Conversion of debt	$ 5,210,962	0	0	5,210,962
Conversion of debt (Shares)	1,307,798
Issuance of common shares	$ 5,470,000	0	0	5,470,000
Issuance of common shares (Shares)	1,461,250
Stock-based compensation	$ 0	585,442	0	585,442
Net loss and comprehensive loss for the period	0	0	(3,632,859)	(3,632,859)
Ending Balance at Jun. 30, 2024	$ 29,442,212	719,980	(23,088,604)	7,073,588
Ending Balance (Shares) at Jun. 30, 2024	10,846,721
Beginning Balance at Dec. 31, 2024	$ 30,518,195	1,520,412	(28,903,903)	$ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024	11,816,721			11,816,721
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs	$ 2,076,507	1,612,474	0	$ 3,688,981
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs (Shares)	1,490,000
Issuance of common shares in connection with SEPA offering costs	$ 300,000	0	0	300,000
Issuance of common shares in connection with SEPA offering costs (Shares)	105,840
Issuance of common shares upon exercise of stock warrants	$ 14,000	0	0	14,000
Issuance of common shares upon exercise of stock warrants (Shares)	5,000
Stock-based compensation	$ 0	112,277	0	112,277
Net loss and comprehensive loss for the period	0	0	(5,102,408)	(5,102,408)
Ending Balance at Mar. 31, 2025	$ 32,908,702	3,245,163	(34,006,311)	2,147,554
Ending Balance (Shares) at Mar. 31, 2025	13,417,561
Beginning Balance at Dec. 31, 2024	$ 30,518,195	1,520,412	(28,903,903)	$ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024	11,816,721			11,816,721
Net loss and comprehensive loss for the period				$ (11,278,492)
Ending Balance at Jun. 30, 2025	$ 37,833,999	5,597,106	(40,182,395)	$ 3,248,710
Ending Balance (Shares) at Jun. 30, 2025	15,936,266			15,936,266
Beginning Balance at Mar. 31, 2025	$ 32,908,702	3,245,163	(34,006,311)	$ 2,147,554
Beginning Balance (Shares) at Mar. 31, 2025	13,417,561
Issuance of common shares in connection with equity financing	$ 3,961,899	2,234,495		6,196,394
Issuance of common shares in connection with equity financing (Shares)	2,260,000
Issuance of common shares upon exercise of stock warrants	$ 963,398	0	0	963,398
Issuance of common shares upon exercise of stock warrants (Shares)	258,705
Stock-based compensation	$ 0	117,448	0	117,448
Net loss and comprehensive loss for the period	0	0	(6,176,084)	(6,176,084)
Ending Balance at Jun. 30, 2025	$ 37,833,999	$ 5,597,106	$ (40,182,395)	$ 3,248,710
Ending Balance (Shares) at Jun. 30, 2025	15,936,266			15,936,266